Dhanusha Sabanathan
85 posts











#OP1250 (#palazestrant) oral CERAN presented by Dr. Lin. - 42% pts 3 lines or greater - CBR 40% in all comers, CBR 52% among ESR1m - mPFS 4.6 mo in all comers, 5.6 mo among ESR1m - among just 2/3L pts like EMERALD, PFS around 7 months #ESMO23 #bcsm

Lucky to have @oncology_bg presenting at Nepean Hospital today on Pitfalls of Interpretation of Clinical Trials. Looking forward to hearing him talk at the @MOGA_ORG ASM #moga23 @NBMLHD

Job Opportunity: MQ Health seeks a Medical Oncology Fellow - Clinical Trials Unit. Full-time. Location: Sydney. Applications Close 26 July. More info: moga.org.au/oncology-posit…

📢(1/5) Just published in @Nature_NPJ Breast Cancer our study assessing how Oncotype DX results impact physicians' confidence and concordance in adjuvant chemotherapy recommendations for early breast cancer patients. Read more: 📌rdcu.be/dd3nv 👇👇👇
















